Autoimmune pancreatitis type 2.

Published on Sep 1, 2020in Current Opinion in Gastroenterology3.225
· DOI :10.1097/MOG.0000000000000655
Nicolò de Pretis8
Estimated H-index: 8
(University of Verona),
Luca Frulloni58
Estimated H-index: 58
Sources
Abstract
PURPOSE OF REVIEW Type 2 autoimmune pancreatitis (AIP) is a rare inflammatory disease of the pancreas. Very few data have been published on this particular subtype, which differs from the 'classical' IgG4-related type 1 AIP in terms of pathological features, epidemiology and risk of relapse. The aim of the current review is to summarize the available literature, suggesting a diagnostic and therapeutic approach to this disease. RECENT FINDINGS Based on the International Consensus Diagnostic Criteria, to achieve a 'definitive' diagnosis of type 2 AIP, histology is required. If a definitive histological diagnosis is lacking (not-performed or inconclusive), concomitant presence of inflammatory bowel disease (IBD) and effective response to steroids are needed for a 'probable' diagnosis of type 2 AIP. SUMMARY Type 2 AIP is a selective pancreatic disease, without association to other organ involvement. The lack of validated serological markers makes the diagnosis challenging in clinical practice, particularly in focal forms. A careful evaluation of the clinical profile (especially of a concomitant IBD), associated with an accurate imaging, might help in clinical practice to suspect type 2 AIP. Response to steroids is crucial to achieve diagnosis in patients without a diagnostic histology.
📖 Papers frequently viewed together
132 Citations
14 Citations
References0
Newest
#1Nicolò de Pretis (University of Verona)H-Index: 8
#2Filippo Vieceli (University of Verona)H-Index: 2
Last. Luca Frulloni (University of Verona)H-Index: 58
view all 6 authors...
Abstract Background Autoimmune pancreatitis (AIP) is a well-recognized fibroinflammatory disease of the pancreas. Despite the significant number of studies published on AIP type 1 and 2, no studies have been focused on AIP type not otherwise specified (NOS) and therefore very little is known about clinical features and long-term outcomes of these patients. The aim of this study was to investigate clinical and radiological features of AIP type NOS-patients. Methods Patients classified as AIP type...
2 CitationsSource
#1Riccardo NegrelliH-Index: 10
#2Enrico BoninsegnaH-Index: 6
Last. Roberto Pozzi MucelliH-Index: 37
view all 8 authors...
OBJECTIVES: This study aimed to evaluate magnetic resonance imaging findings of autoimmune pancreatitis (AIP) and to find radiological patterns that could differentiate type 1 and type 2 AIP. METHODS: Eighty-four patients with diagnosis of AIP were enrolled. Image analysis included pancreatic signal intensity abnormalities, enhancement pattern, extrapancreatic involvement, and main pancreatic duct alterations. RESULTS: Pancreatic parenchyma resulted in hypointensity on T1-weighted images in 65 (...
3 CitationsSource
#1Nicolò de Pretis (University of Verona)H-Index: 8
#2Antonio Amodio (University of Verona)H-Index: 13
Last. Luca Frulloni (University of Verona)H-Index: 58
view all 3 authors...
ABSTRACTIntroduction: Autoimmune Pancreatitis (AIP) is a peculiar form of pancreatitis different from all other type of pancreatitis (‘one like no one pancreatitis’) and characterized by a dramatic response to steroids. AIP can be classified histologically in type 1, included in a larger group of diseases named IgG4-related disease, and type 2. At imaging, AIP may involve all (diffuse form) or only a part (focal form) of the pancreatic gland.Areas covered: In this article, the clinical approach ...
5 CitationsSource
#1Sunyoung Lee (UOU: University of Ulsan)H-Index: 15
#2Jin Hee Kim (UOU: University of Ulsan)H-Index: 21
Last. Seung Soo Lee (UOU: University of Ulsan)H-Index: 30
view all 8 authors...
Objectives To intraindividually compare the diagnostic performance of CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis (AIP) from pancreatic ductal adenocarcinoma (PDA).
12 CitationsSource
Background & Aims Few people know of autoimmune pancreatitis (AIP), a rare disorder associated with inflammatory bowel diseases (IBD). We aimed to describe phenotype and outcomes of IBD and AIP when associated. Methods We performed a retrospective study of cases of AIP in IBD identified from the multicenter Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif in Belgium and France from July 2012 through July 2015. Patients were diagnosed with AIP based on the International...
15 CitationsSource
#1Sönke Detlefsen (OUH: Odense University Hospital)H-Index: 21
#2Maiken Thyregod Joergensen (OUH: Odense University Hospital)H-Index: 10
Last. Michael Bau Mortensen (OUH: Odense University Hospital)H-Index: 20
view all 3 authors...
The International Consensus Diagnostic Criteria (ICDC) for the diagnosis of autoimmune pancreatitis (AIP) include the histological criterion that is based on either pancreatic core needle biopsies (CNBs) or surgical specimens. However, CNBs are difficult to obtain by endoscopic ultrasound (EUS). EUS fine-needle aspiration (EUS-FNA) cytology is usually not sufficient for the diagnosis of AIP, but may sometimes contain tissue microfragments. Another approach is EUS-guided histological fine-needle ...
14 CitationsSource
#1Kazuichi Okazaki (Kansai Medical University)H-Index: 83
#2Suresh T. Chari (Mayo Clinic)H-Index: 103
Last. Tooru Shimosegawa (Tohoku University)H-Index: 93
view all 11 authors...
Abstract Background and aims The International Consensus Diagnostic Criteria (ICDC) for AIP has proposed two distinctive type of AIP, type 1 and type 2, and enabled us first to differentiate two types of AIP each other. By initial steroid treatment for induction of remission, remission can be successfully induced in almost all subjects with type 1 and type 2 AIP. As relapse rate in type 1 AIP is significantly higher than in type 2 AIP, there has been ongoing debate on how to treat effectively re...
71 CitationsSource
#1Phil A. Hart (Mayo Clinic)H-Index: 28
#2Michael J. Levy (Mayo Clinic)H-Index: 90
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 13 authors...
Objective Idiopathic duct-centric chronic pancreatitis (IDCP), also known as type 2 autoimmune pancreatitis (AIP), is an uncommon subtype of AIP. International Consensus Diagnostic Criteria for IDCP propose that the diagnosis requires pancreatic histology and/or concurrent IBD. We examined our experience with IDCP (type 2 AIP) to assess the appropriateness of these criteria, and identify unique characteristics in patients presenting with acute pancreatitis. Design We reviewed the Mayo Clinic AIP...
34 CitationsSource
#1Shigeyuki Kawa (Shinshu University)H-Index: 67
#2Kazuichi Okazaki (Kansai Medical University)H-Index: 83
Last. Tooru Shimosegawa (Tokyo Medical and Dental University)H-Index: 1
view all 5 authors...
Background Two types of autoimmune pancreatitis (AIP) have been reported, lymphoplasmacytic sclerosing pancreatitis and idiopathic duct-centric chronic pancreatitis (IDCP), which are now recognized as type 1 and type 2 AIP, respectively. Since the clinical features of type 2 AIP have not been fully elucidated and this condition is frequently accompanied by inflammatory bowel disease (IBD), we performed a nationwide survey of patients with AIP complicated with IBD to precisely characterize this d...
17 CitationsSource
#1Francesco VitaliH-Index: 2
#2Torsten HansenH-Index: 27
Last. Luca FrulloniH-Index: 58
view all 10 authors...
ObjectivesA diagnosis of benign lesions (BLs) is reported in 5% to 21% of pancreatoduodenectomies performed for neoplasms; no data for body-tail resections are available. The aims were to investigate the frequency and characterize the BLs mimicking cancer in the head and the body-tail of the pancrea
12 CitationsSource
Cited By0
Newest